SEC Form 4 · accession 0001127602-16-067703
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Rolih
Officer — EVP, Global Reg & Quality Syst
Period of report
Nov 16, 2016
Accepted (ET)
Nov 18, 2016 · 10:10 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 164,160 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $16.85 | Nov 16, 2016 | A | 10,000 | A | — | Nov 16, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1These options are awarded under the 2012 Stock Incentive Plan in connection with promotion to Executive Vice President, Global Regulatory and Quality Systems, and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on November 16, 2020).